By using DiabetesTimes.co.uk, you agree to our terms and use of cookies to enhance your experience.
A new molecule that could be used as a biological ‘marker’ in the early diagnosis of type 1 diabetes has been discovered by researchers. The findings found that miR-409-3p reduced both in mice ...
A drug that targets the immune system can delay type 1 diabetes for a median of two years in children and adults at high risk, according to findings from a mid-stage trial. The research was ...
Diabetes UK and JDRF have announced a £490,000 research project to fund the “next generation” of immunotherapy research for type 1 diabetes. The award will allow for more clinical ...
A major type 1 diabetes organisation has joined forced with other charities to launch a first-of-its-kind research project to tackle the UK’s high prevalence of autoimmune conditions. JDRF has ...
Two major diabetes charities have announced that they are set to merge. Type 1 diabetes organisation JDRF is to team up with INPUT Patient Advocacy, the UK diabetes technology advocacy charity. A ...
People who use the Animas® Vibe® insulin pumps are being urged to speak to their healthcare professional as it is announced the product is being discontinued immediately. Animas, the ...
A type 1 diabetes charity is to help develop a single pod Automated Insulin Delivery (AID) device with a single entry skin point, it has been announced. JDRF has announced its partnership with ...
More than 300 healthcare professionals will come together for a training event so they can help support people with type 1 diabetes to exercise. The type 1 diabetes charity JDRF’s Performance in ...
An online tool to help people with type 1 diabetes search for and participate in clinical trials, has been launched. The Type 1 Trial Finder tools, which can be accessed via the JDRF website, ...
Closed loop systems improve glucose control while also alleviating the risk of hypoglycaemia in adults, research has shown. The device, otherwise known as the artificial pancreas, is a ...